Publication of Gazette notification in Extraordinary gazette of India.

## Policy Analysis Report: Amendment to Medical Device Vertical Group A and B Posts, Recruitment Rules **1. Executive Summary:** This report analyzes an amendment to the Ministry of Health and Family Welfare, Directorate General of Health Services, Central Drugs Standard Control Organisation, Medical Device Vertical Group A and B Posts, Recruitment Rules, 2024. The amendment, enacted on April 25, 2025, focuses on modifying eligibility criteria for promotion to Assistant Drugs Controller I and qualification requirements for Drugs Inspector Medical Devices positions. Key changes address the consideration of seniors for promotion and revise the acceptable academic background for Drugs Inspectors. **2. Introduction:** This report aims to provide a clear and concise analysis of the amendment to the Ministry of Health and Family Welfare, Directorate General of Health Services, Central Drugs Standard Control Organisation, Medical Device Vertical Group A and B Posts, Recruitment Rules, 2024, based solely on the provided policy text. **3. Policy Overview:** * This document is an *amendment* to the Ministry of Health and Family Welfare, Directorate General of Health Services, Central Drugs Standard Control Organisation, Medical Device Vertical Group A and B Posts, Recruitment Rules, 2024. * The core objective of the amendment, as inferred from the text, is to refine the recruitment and promotion criteria for specific positions within the Medical Device Vertical of the Central Drugs Standard Control Organisation. This includes modifying the eligibility requirements for promotion and widening the field of eligible candidates for certain positions. **4. Background and Rationale:** This amendment likely aims to address potential rigidities or limitations within the original Recruitment Rules, 2024. The change to promotion criteria suggests a need to ensure fairness and consider the experience of senior employees who may be slightly short of the eligibility requirements. The modification of qualification requirements for Drugs Inspectors indicates a desire to broaden the pool of qualified applicants. **5. Key Provisions / Changes:** This amendment introduces two key changes: * **Change 1: Promotion to Assistant Drugs Controller I (Serial Number 4)** * **Original Policy Part Being Changed:** The "Note" under the "promotion" subheading in column 11 of the Schedule, relating to the post of Assistant Drugs Controller I. * **New Rule/Provision:** Two new notes are substituted. * **Note 1:** Allows consideration of seniors for promotion even if they are slightly short of the qualifying service (by no more than half the required service or two years, whichever is less), provided they have successfully completed their probation period. * **Note 2:** Establishes that the eligibility service for incumbents holding the post of Drugs Inspector Medical Devices on a regular basis on the date of commencement of these rules, shall be six years of regular service in the grade. * **Effect of Change:** This change introduces flexibility in the promotion process, enabling the consideration of experienced senior employees who are near the qualifying service threshold. It also sets the service requirements for Drugs Inspectors Medical Devices at six years of regular service in the grade at the time the amendment goes into effect. * **Change 2: Qualification for Drugs Inspector Medical Devices (Serial Number 5)** * **Original Policy Part Being Changed:** The "Qualification" subheading in column 7 of the Schedule, relating to the post of Drugs Inspector Medical Devices. * **New Rule/Provision:** The words "Bachelors of engineering technology in Bio Medical" are replaced with "Bachelors of engineering or technology in Bio Medical". * **Effect of Change:** This change broadens the acceptable qualifications for the Drugs Inspector Medical Devices position, clarifying that a Bachelor of Engineering *or* Technology in BioMedical is acceptable, rather than exclusively requiring a Bachelor of Engineering *Technology*. **6. Target Audience and Stakeholders:** The primary stakeholders directly affected by these changes are: * Current Drugs Inspectors Medical Devices. * Individuals aspiring to become Drugs Inspectors Medical Devices. * Employees of the Central Drugs Standard Control Organisation eligible for promotion to Assistant Drugs Controller I. * The Ministry of Health and Family Welfare, Directorate General of Health Services, and Central Drugs Standard Control Organisation, responsible for implementing these rules. **7. Implementation Aspects (Inferred):** * **Responsible Agency:** The Ministry of Health and Family Welfare, Directorate General of Health Services, Central Drugs Standard Control Organisation. * **Timelines:** The amendment came into force on the date of its publication in the Official Gazette (April 25, 2025). * **Procedures:** The amendment necessitates a review of current promotion and recruitment processes for Assistant Drugs Controller I and Drugs Inspector Medical Devices, ensuring compliance with the revised criteria. **8. Expected Outcomes / Impact of Changes:** * **Promotion Changes:** The changes concerning promotions may lead to a faster or easier career progression of incumbent Drugs Inspectors Medical Devices through the six-year service requirement. Further, the promotion changes could lead to greater employee satisfaction and retention by recognizing the experience of senior staff. * **Qualification Changes:** The change in qualification requirements for Drugs Inspectors could broaden the pool of eligible candidates, potentially improving the quality and diversity of applicants. **9. Conclusion:** This amendment to the Medical Device Vertical Group A and B Posts, Recruitment Rules, 2024, introduces targeted changes to promotion criteria and qualification requirements. The modifications are intended to enhance flexibility, ensure fairness, and broaden the pool of eligible candidates, ultimately contributing to the effective functioning of the Central Drugs Standard Control Organisation's Medical Device Vertical.

Key Entities Referenced